These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23592863)

  • 41. Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies.
    Witkowski B; Amaratunga C; Khim N; Sreng S; Chim P; Kim S; Lim P; Mao S; Sopha C; Sam B; Anderson JM; Duong S; Chuor CM; Taylor WR; Suon S; Mercereau-Puijalon O; Fairhurst RM; Menard D
    Lancet Infect Dis; 2013 Dec; 13(12):1043-9. PubMed ID: 24035558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.
    Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B
    Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of mutations in Plasmodium falciparum genes associated with resistance to different antimalarial drugs in Nyando, Kisumu County in Kenya.
    Musyoka KB; Kiiru JN; Aluvaala E; Omondi P; Chege WK; Judah T; Kiboi D; Nganga JK; Kimani FT
    Infect Genet Evol; 2020 Mar; 78():104121. PubMed ID: 31756512
    [TBL] [Abstract][Full Text] [Related]  

  • 44.
    Montenegro M; Neal AT; Posada M; De Las Salas B; Lopera-Mesa TM; Fairhurst RM; Tobon-Castaño A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28947476
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance.
    Jones S; Hodel EM; Sharma R; Kay K; Hastings IM
    J Infect Dis; 2019 Apr; 219(8):1243-1253. PubMed ID: 30517708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A major genome region underlying artemisinin resistance in malaria.
    Cheeseman IH; Miller BA; Nair S; Nkhoma S; Tan A; Tan JC; Al Saai S; Phyo AP; Moo CL; Lwin KM; McGready R; Ashley E; Imwong M; Stepniewska K; Yi P; Dondorp AM; Mayxay M; Newton PN; White NJ; Nosten F; Ferdig MT; Anderson TJ
    Science; 2012 Apr; 336(6077):79-82. PubMed ID: 22491853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Slow parasite clearance, absent K13-propeller gene polymorphisms and adequate artesunate levels among patients with malaria: A pilot study from southern India.
    Miraclin TA; Mathew BS; Mammen JJ; Ramachandran SV; Kumar S; Bhattacharjee S; Sudarsanam TD; Sathyendra S; Prabhakar Abhilash KP; Jayaseelan V; Rupali P
    Natl Med J India; 2019; 32(4):200-206. PubMed ID: 32769239
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013.
    Liu H; Yang HL; Tang LH; Li XL; Huang F; Wang JZ; Li CF; Wang HY; Nie RH; Guo XR; Lin YX; Li M; Wang J; Xu JW
    Malar J; 2015 Feb; 14():47. PubMed ID: 25652213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in Nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies.
    Gbotosho GO; Sowunmi A; Happi CT; Okuboyejo TM
    Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):685-90. PubMed ID: 22012222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insight into k13-propeller gene polymorphism and ex vivo DHA-response profiles from Cameroonian isolates.
    Menard S; Tchoufack JN; Maffo CN; Nsango SE; Iriart X; Abate L; Tsapi MT; Awono-Ambéné PH; Abega Mekongo FA; Morlais I; Berry A
    Malar J; 2016 Nov; 15(1):572. PubMed ID: 27887614
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of oral and intravenous artesunate in male Tanzanian adults with Plasmodium falciparum malaria and in vitro susceptibility to artemisinin, chloroquine, and mefloquine.
    Alin MH; Kihamia CM; Bjorkman A; Bwijo BA; Premji Z; Mtey GJ; Ashton M
    Am J Trop Med Hyg; 1995 Dec; 53(6):639-45. PubMed ID: 8561267
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated
    Roth JM; Sawa P; Omweri G; Makio N; Osoti V; de Jong MD; Schallig HDFH; Mens PF
    Am J Trop Med Hyg; 2018 Oct; 99(4):970-977. PubMed ID: 30105967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and parasite clearance of artemisinin-resistant Plasmodium falciparum infection: A pilot and a randomised volunteer infection study in Australia.
    Watts RE; Odedra A; Marquart L; Webb L; Abd-Rahman AN; Cascales L; Chalon S; Rebelo M; Pava Z; Collins KA; Pasay C; Chen N; Peatey CL; Möhrle JJ; McCarthy JS
    PLoS Med; 2020 Aug; 17(8):e1003203. PubMed ID: 32822347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of children with malaria Plasmodium falciparum with derivatives artemisinin].
    Alecrim Md; Carvalho LM; Andrade SD; Arcanjo AR; Alexandre MA; Alecrim WD
    Rev Soc Bras Med Trop; 2003; 36(2):223-6. PubMed ID: 12806458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inferred relatedness and heritability in malaria parasites.
    Anderson TJ; Williams JT; Nair S; Sudimack D; Barends M; Jaidee A; Price RN; Nosten F
    Proc Biol Sci; 2010 Aug; 277(1693):2531-40. PubMed ID: 20392725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. K13 Propeller Mutations in Plasmodium falciparum Populations in Regions of Malaria Endemicity in Vietnam from 2009 to 2016.
    Thuy-Nhien N; Tuyen NK; Tong NT; Vy NT; Thanh NV; Van HT; Huong-Thu P; Quang HH; Boni MF; Dolecek C; Farrar J; Thwaites GE; Miotto O; White NJ; Hien TT
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic diversity and lack of artemisinin selection signature on the Plasmodium falciparum ATP6 in the Greater Mekong Subregion.
    Miao M; Wang Z; Yang Z; Yuan L; Parker DM; Putaporntip C; Jongwutiwes S; Xangsayarath P; Pongvongsa T; Moji H; Dinh Tuong T; Abe T; Nakazawa S; Kyaw MP; Yan G; Sirichaisinthop J; Sattabongkot J; Mu J; Su XZ; Kaneko O; Cui L
    PLoS One; 2013; 8(3):e59192. PubMed ID: 23555629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasmodium falciparum clearance rates in response to artesunate in Malian children with malaria: effect of acquired immunity.
    Lopera-Mesa TM; Doumbia S; Chiang S; Zeituni AE; Konate DS; Doumbouya M; Keita AS; Stepniewska K; Traore K; Diakite SA; Ndiaye D; Sa JM; Anderson JM; Fay MP; Long CA; Diakite M; Fairhurst RM
    J Infect Dis; 2013 Jun; 207(11):1655-63. PubMed ID: 23448727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased prevalence of the Plasmodium falciparum Pfmdr1 86N genotype among field isolates from Franceville, Gabon after replacement of chloroquine by artemether-lumefantrine and artesunate-mefloquine.
    Lekana-Douki JB; Dinzouna Boutamba SD; Zatra R; Zang Edou SE; Ekomy H; Bisvigou U; Toure-Ndouo FS
    Infect Genet Evol; 2011 Mar; 11(2):512-7. PubMed ID: 21251998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Malaria Parasite Clearance: What Are We Really Measuring?
    Khoury DS; Zaloumis SG; Grigg MJ; Haque A; Davenport MP;
    Trends Parasitol; 2020 May; 36(5):413-426. PubMed ID: 32298629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.